PT - JOURNAL ARTICLE AU - Miao, Congliang AU - Jin, Mengdi AU - Miao, Li AU - Yang, Xinying AU - Huang, Peng AU - Xiong, Huanwen AU - Huang, Peijie AU - Zhao, Qi AU - Du, Jiang AU - Hong, Jiang TI - Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study AID - 10.1101/2020.03.24.20042432 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.24.20042432 4099 - http://medrxiv.org/content/early/2020/03/26/2020.03.24.20042432.short 4100 - http://medrxiv.org/content/early/2020/03/26/2020.03.24.20042432.full AB - Objective The purpose of this study is to distinguish the imaging features of COVID-19 with other chest infectious diseases and evaluate diagnostic value of chest CT for suspected patients.Methods Adult suspected patients aged>18 years within 14 days who underwent chest CT scan and reverse-transcription polymerase-chain-reaction (RT-PCR) tests were enrolled. The enrolled patients were confirmed and grouped according to results of RT-PCR tests. The data of basic demographics, single chest CT features, and combined chest CT features were analyzed for confirmed and non-confirmed groups.Results A total of 130 patients were enrolled with 54 cases positive and 76 cases negative. The typical CT imaging features of positive group were ground glass opacity (GGO), crazy-paving pattern and air bronchogram. The lesions were mostly distributed bilaterally, close to the lower lungs or the pleura. When features combined, GGO with bilateral pulmonary distribution and GGO with pleural distribution were more common, of which were 31 cases (57.4%) and 30 cases (55.6%) respectively. The combinations were almost presented statistically significant (P<0.05) except for the combination of GGO with consolidation. Most combinations presented relatively low sensitivity but extremely high specificity. The average specificity of these combinations is around 90%.Conclusions The combinations of GGO could be useful in the identification and differential diagnosis of COVID-19, which alerts clinicians to isolate patients for treatment promptly and repeat RT-PCR tests until incubation ends.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data of this manuscript is available.2019-nCoV2019 novel coronavirusCOVID-19Corona Virus Disease 2019RT-PCRreverse-transcription polymerase-chain-reactionHRCTHigh-resolution computed tomographyGGOGround glass opacityMERSMiddle East respiratory syndromeSARSSevere acute respiratory syndromeBALFBronchoalveolar lavage fluid